Quince Therapeutics Inc QNCX Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates by Over 200 DLTR Q1 2026 Earnings Small EPS Miss Amid Cautious Consumer Spending CNMD Q1 2026 Earnings Adjusted EPS Surpasses Consensus Shares Edge Higher NMRA Q1 2026 Earnings NarrowerthanExpected Loss Reflects Disciplined Spending MGEE Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Performance PRME Q1 2026 Earnings EPS Worse Than Expected as PreRevenue Biotech Advances Pipeline